Attached files
| file | filename |
|---|---|
| EX-31.2 - EXHIBIT 31.2 - Insys Therapeutics, Inc. | ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Insys Therapeutics, Inc. | ex31-1.htm |
| EX-21.1 - EXHIBIT 21.1 - Insys Therapeutics, Inc. | ex21-1.htm |
| EX-23.1 - EXHIBIT 23.1 - Insys Therapeutics, Inc. | ex23-1.htm |
| EX-10.12 - EXHIBIT 10.12 - Insys Therapeutics, Inc. | ex10-12.htm |
| 10-K - FORM 10-K - Insys Therapeutics, Inc. | insy20151231_10k.htm |
Exhibit 32
Certification Pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
For purposes of Section 1350 of Chapter 63 of Title 18 of the United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned officers of Insys Therapeutics, Inc., a Delaware corporation (“Company”), does hereby certify, to such officer’s knowledge, that:
The Annual Report on Form 10-K for the fiscal year ended December 31, 2015 (“Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Dated: February 26, 2016 |
|
/s/ John N. Kapoor |
|
|
|
Dr. John N. Kapoor |
|
|
|
President and Chief Executive Officer |
|
|
|
|
|
Dated: February 26, 2016 |
|
/s/ Darryl S. Baker |
|
|
|
Darryl S. Baker |
|
|
|
Chief Financial Officer |